Skip to main content

Want a detailed portfolio tracker?

Immuneering (IMRX) P/E (2021 - 2026)

Immuneering (IMRX) P/E from Jul 30, 2021 to Jul 21, 2026. The TTM Immuneering (IMRX) P/E is -3.16. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immuneering (IMRX)

YearP/EChange
2026-3.16-18.71%
2025-3.89+232.85%
2024-1.17-70.47%
2023-3.96+53.38%
2022-2.58-32.54%
2021-3.83N/A

Comparison Immuneering (IMRX) P/E with competitors

Immuneering (IMRX) P/E is -3.16.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.14%
ENLVEnlivex Ltd0.07-102.36%
FGENFibroGen Inc0.24-107.59%
CHRSCoherus Biosciences Inc0.85-126.82%
FBIOFortress Biotech Inc0.95-130.00%
ORMPOramed Pharmaceuticals Inc1.50-147.51%
AGENAgenus Inc3.01-195.13%
INVAInnoviva Inc3.15-199.70%
VXRTVaxart Inc3.55-212.21%
CRMDCorMedix Inc3.63-214.69%
CVACCureVac N.V.4.45-240.53%
GLPGGalapagos NV4.86-253.59%
SRPTSarepta Therapeutics Inc4.88-254.32%
ABEOAbeona Therapeutics Inc5.39-270.30%
ABUSArbutus Biopharma Corp5.60-276.88%
ZVRAZevra Therapeutics Inc5.89-286.10%
SPROSpero Therapeutics Inc6.23-296.88%
CGENCompugen Ltd6.31-299.58%
RIGLRigel Pharmaceuticals6.87-317.23%
SLXNSilexion Therapeutics Corp7.30-330.63%
OMEROmeros Corporation9.26-392.67%
AUPHAurinia Pharmaceuticals Inc9.58-402.98%
PLXProtalix BioTherapeutics Inc10.89-444.27%
ACADAcadia Pharmaceuticals Inc11.73-470.74%
TBPHTheravance Biopharma Inc12.26-487.61%
ADMAAdma Biologics Inc12.42-492.54%
HRMYHarmony Biosciences Holdings Inc13.82-536.86%
SABSSAB Biotherapeutics Inc14.14-546.85%
NAGENiagen Bioscience Inc14.82-568.40%
INCYIncyte Corp15.82-600.15%
REGNRegeneron Pharmaceuticals Inc15.86-601.23%
PBYIPuma Biotechnology Inc17.32-647.35%
CPRXCatalyst Pharmaceuticals Inc17.44-651.26%
EXELExelixis Inc17.54-654.38%
TGTXTG Therapeutics Inc18.97-699.52%
MDXGMimedx Group Inc20.55-749.67%
XOMAXOMA Royalty Corp22.87-823.09%
ARGXArgen X SE24.30-868.08%
CTMXCytomX Therapeutics Inc24.82-884.62%
XOMAOXOMA Royalty Corp25.34-901.17%
HALOHalozyme Therapeutics Inc25.62-909.99%
XOMAPXOMA Royalty Corp25.67-911.46%
VRTXVertex Pharmaceuticals Inc27.99-984.94%
RPRXRoyalty Pharma plc - Class A28.69-1006.84%
SLNOSoleno Therapeutics Inc29.02-1017.20%
ASNDAscendis Pharma A/S30.09-1051.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1298.44%
APLSApellis Pharmaceuticals Inc39.02-1333.50%
BMRNBiomarin Pharmaceutical Inc42.21-1434.36%
KRYSKrystal Biotech Inc45.34-1533.35%
ONCBeiGene Ltd69.54-2298.24%
PHARPharming Group N.V.75.03-2471.63%
TECHBio-Techne Corp101.96-3323.00%
VCELVericel Corp109.92-3574.72%
ALNYAlnylam Pharmaceuticals Inc117.96-3828.99%
GMABGenmab140.29-4534.73%
TLXTelix Pharmaceuticals Ltd162.15-5225.81%
CORTCorcept Therapeutics Inc212.86-6828.63%